Literature DB >> 28532247

High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: results from the TRAPID-AMI study.

Richard Nowak1, Christian Mueller2, Evangelos Giannitsis3, Michael Christ4, Jordi Ordonez-Llanos5, Christopher DeFilippi6, James McCord7, Richard Body8, Mauro Panteghini9, Tomas Jernberg10, Mario Plebani11, Franck Verschuren12, John K French13, Robert Christenson14, Gordon Jacobsen15, Carina Dinkel16, Bertil Lindahl17.   

Abstract

PURPOSE: To describe the baseline, 1 hr and delta high sensitivity cardiac troponin (hs-cTnT) values in patients with suspected acute myocardial infarction (AMI) but without a final acute coronary syndrome (ACS) diagnosis.
MATERIALS AND METHODS: hs-cTnT assay for RAPID rule out of acute myocardial infarction (TRAPID-AMI) was a prospective diagnostic trial that enrolled emergency department (ED) patients with suspected AMI. Final patient diagnoses were adjudicated by a clinical events committee and subjects placed in different clinical groups: AMI, unstable angina, non-ACS cardiac, non-cardiac and unknown origin. The baseline, 1 hr and delta hs-cTnT values were analysed in the 902 non-ACS patients.
RESULTS: Amongst the 1282 studied the patient groups were 213 (17%) AMI, 167 (13%) unstable angina, 113 (9%) non-ACS cardiac, 288 (22%) non-cardiac and 501 (39%) unknown origin. The hs-cTnT values in the non-cardiac and unknown origin groups were combined. The median hs-cTnT values (ng/L) were higher (p < 0.001) in the non-ACS cardiac compared to the non-cardiac/unknown origin group at baseline (11.8, <5) and 1 hr (12.3, <5). Their negative predictive values were 0.955 (baseline) and 0.954 (1 hr) for predicting non-ACS cardiac versus non-cardiac/unknown origin diagnoses.
CONCLUSIONS: Hs-cTnT may help predict whether non-ACS ED patients have a final non-ACS cardiac or non-cardiac/unknown origin diagnoses.

Entities:  

Keywords:  High sensitivity troponin; emergency department; non ACS patients

Mesh:

Substances:

Year:  2017        PMID: 28532247     DOI: 10.1080/1354750X.2017.1334154

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  5 in total

Review 1.  [Biomarkers in the diagnosis of cardiovascular emergencies : Acute coronary syndrome and differential diagnoses].

Authors:  Martin Möckel
Journal:  Internist (Berl)       Date:  2019-06       Impact factor: 0.743

2.  Plasma Metabolites Alert Patients With Chest Pain to Occurrence of Myocardial Infarction.

Authors:  Nan Aa; Ying Lu; Mengjie Yu; Heng Tang; Zhenyao Lu; Runbing Sun; Liansheng Wang; Chunjian Li; Zhijian Yang; Jiye Aa; Xiangqing Kong; Guangji Wang
Journal:  Front Cardiovasc Med       Date:  2021-04-23

3.  Clinical features and prognosis of patients with acute non-specific chest pain in emergency and cardiology departments after the introduction of high-sensitivity troponins: a prospective cohort study.

Authors:  Nivethitha Ilangkovan; Hans Mickley; Axel Diederichsen; Annmarie Lassen; Thomas L Sørensen; Hussam Mahmoud Sheta; Peter B Stæhr; Christian Backer Mogensen
Journal:  BMJ Open       Date:  2017-12-22       Impact factor: 2.692

4.  Prevalence of coronary artery calcification in a non-specific chest pain population in emergency and cardiology departments compared with the background population: a prospective cohort study in Southern Denmark with 12-month follow-up of cardiac endpoints.

Authors:  Nivethitha Ilangkovan; Christian Backer Mogensen; Hans Mickley; Annmarie Touborg Lassen; Jess Lambrechtsen; Niels Peter Ronnow Sand; Rasmus Albiniussen; Jørgen Byg; Flemming Hald Steffensen; Mette Hjortdal Grønhøj; Axel Diederichsen
Journal:  BMJ Open       Date:  2018-03-03       Impact factor: 2.692

Review 5.  Type 2 MI and Myocardial Injury in the Era of High-sensitivity Troponin.

Authors:  Rifly Rafiudeen; Peter Barlis; Harvey D White; William van Gaal
Journal:  Eur Cardiol       Date:  2022-02-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.